Features of the hemostasis system in polycythemia vera in children

Patients with polycythemia vera (PV) are at an increased risk for thrombosis. Abnormalities in coagulation parameters and global hemostasis tests can help with hypercoagulation recognition in PV. The purpose of this research was to analyze the features of changes in laboratory parameters of the hemostasis system in pediatric patients with PV. Materials and methods used: a single-center retrospective cohort study of clinical records of 32 (11 (35%) girls/21 (65%) boys aged 11.5 [0.8; 17.5] y/o) pediatric (all under the age of 18 y/o) PV patients who were admitted at the National Scientific and Practical Center for Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev (Moscow, Russia) in Jan. 2012-June 2024 was conducted. Laboratory parameters were determined prior to the beginning of the antiplatelet and cytoreductive therapy. Results: in 20 (62.5%) and 4 (12.5%) patients, mutations in the JAK2V617F and JAK2 ex 12 genes were detected, respectively, the remaining 8 (25%) children were JAK2-negative. In total, there were 8 (72%) JAK2-positive girls and 15 (71%) boys; gender did not statistically significantly affect the presence of a driver mutation (p=0.939). Both the median and the mean values of the main parameters of the blood coagulation system were within the reference values. The thromboelastography parameters did not deviate from the reference values for the parameters. According to the results of the thrombodynamics study, the average value of the initial clot growth rate among all patients was increased and amounted to 58.3±5.07 μm/min, the steady-state velocity also increased among all patients to 29.5±4.3 μm/min, the median and the mean values of the remaining parameters were within the reference intervals. Conclusion: the parameters of standard coagulogram and thromboelastography tests in pediatric PV patients had no deviations. The average values of thrombodynamics (initial and steady-state clot growth rate) were increased, which potentially indicates the hypercoagulation.

Authors

Publication Details

Journal
PEDIATRIA Journal named after G N SPERANSKY
Published
2024-12-07
DOI
https://doi.org/10.24110/0031-403x-2024-103-6-25-32
Citations
2
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Features of the hemostasis system in polycythemia vera in children

P. А. Zharkov, А. V. Pshonkin, A. V. Poletaev, Anastasia N. Sveshnikova et al.
2 citations
PEDIATRIA Journal named after G N SPERANSKY
Myeloproliferative Neoplasms: Diagnosis and Treatment
0.88
article

Features of the hemostasis system in polycythemia vera in children

P. А. Zharkov, А. V. Pshonkin, A. V. Poletaev, Anastasia N. Sveshnikova, A. V. Bogdanov, N.S. Smetanina
article en
2 citations

Abstract

Patients with polycythemia vera (PV) are at an increased risk for thrombosis. Abnormalities in coagulation parameters and global hemostasis tests can help with hypercoagulation recognition in PV. The purpose of this research was to analyze the features of changes in laboratory parameters of the hemostasis system in pediatric patients with PV. Materials and methods used: a single-center retrospective cohort study of clinical records of 32 (11 (35%) girls/21 (65%) boys aged 11.5 [0.8; 17.5] y/o) pediatric (all under the age of 18 y/o) PV patients who were admitted at the National Scientific and Practical Center for Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev (Moscow, Russia) in Jan. 2012-June 2024 was conducted. Laboratory parameters were determined prior to the beginning of the antiplatelet and cytoreductive therapy. Results: in 20 (62.5%) and 4 (12.5%) patients, mutations in the JAK2V617F and JAK2 ex 12 genes were detected, respectively, the remaining 8 (25%) children were JAK2-negative. In total, there were 8 (72%) JAK2-positive girls and 15 (71%) boys; gender did not statistically significantly affect the presence of a driver mutation (p=0.939). Both the median and the mean values of the main parameters of the blood coagulation system were within the reference values. The thromboelastography parameters did not deviate from the reference values for the parameters. According to the results of the thrombodynamics study, the average value of the initial clot growth rate among all patients was increased and amounted to 58.3±5.07 μm/min, the steady-state velocity also increased among all patients to 29.5±4.3 μm/min, the median and the mean values of the remaining parameters were within the reference intervals. Conclusion: the parameters of standard coagulogram and thromboelastography tests in pediatric PV patients had no deviations. The average values of thrombodynamics (initial and steady-state clot growth rate) were increased, which potentially indicates the hypercoagulation.

PEDIATRIA Journal named after G N SPERANSKYVol. 103(6)
Good health and well-being
Openalex Percentile: Top 22%
Myeloproliferative Neoplasms: Diagnosis and Treatment
0.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.